A detailed history of Versant Capital Management, Inc transactions in Viatris Inc stock. As of the latest transaction made, Versant Capital Management, Inc holds 2,363 shares of VTRS stock, worth $25,733. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,363
Previous 702 236.61%
Holding current value
$25,733
Previous $8,000 262.5%
% of portfolio
0.01%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 02, 2025

BUY
$11.32 - $13.37 $18,802 - $22,207
1,661 Added 236.61%
2,363 $29,000
Q3 2024

Oct 07, 2024

BUY
$10.32 - $12.13 $1,238 - $1,455
120 Added 20.62%
702 $8,000
Q2 2024

Jul 05, 2024

BUY
$10.05 - $12.02 $10 - $12
1 Added 0.17%
582 $6,000
Q1 2024

Apr 03, 2024

SELL
$11.27 - $13.53 $191 - $230
-17 Reduced 2.84%
581 $6,000
Q4 2023

Jan 08, 2024

BUY
$8.77 - $10.85 $780 - $965
89 Added 17.49%
598 $6,000
Q3 2023

Oct 11, 2023

SELL
$9.59 - $11.35 $374 - $442
-39 Reduced 7.12%
509 $5,000
Q2 2023

Jul 10, 2023

BUY
$9.02 - $10.29 $153 - $174
17 Added 3.2%
548 $5,000
Q1 2023

Apr 10, 2023

BUY
$9.2 - $12.26 $846 - $1,127
92 Added 20.96%
531 $5,000
Q4 2022

Jan 25, 2023

SELL
$8.72 - $11.56 $10,472 - $13,883
-1,201 Reduced 73.23%
439 $0
Q3 2022

Dec 30, 2022

BUY
$8.48 - $11.13 $6,139 - $8,058
724 Added 79.04%
1,640 $14,000
Q2 2022

Aug 02, 2022

BUY
$9.95 - $12.27 $4,805 - $5,926
483 Added 111.55%
916 $10,000
Q1 2022

Apr 29, 2022

BUY
$9.81 - $15.4 $637 - $1,001
65 Added 17.66%
433 $5,000
Q4 2021

Jan 06, 2022

SELL
$12.09 - $14.68 $108 - $132
-9 Reduced 2.39%
368 $5,000
Q3 2021

Oct 29, 2021

SELL
$13.25 - $15.13 $410 - $469
-31 Reduced 7.6%
377 $5,000
Q2 2021

Jul 22, 2021

SELL
$12.97 - $16.15 $2,840 - $3,536
-219 Reduced 34.93%
408 $6,000
Q1 2021

Apr 27, 2021

BUY
$13.59 - $18.54 $8,520 - $11,624
627 New
627 $9,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.